---
document_datetime: 2023-09-21 20:02:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/quinsair-epar-all-authorised-presentations_en.pdf
document_name: quinsair-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7585112
conversion_datetime: 2025-12-22 10:52:53.734621
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                         |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-----------------------------------|
| EU/1/14/973/001  | Quinsair          | 240 mg     | Nebuliser solution    | Inhalation use            | Ampoule (LDPE)        | 2.4 mL (100 mg/mL)        | 56 Ampoules + 1 Nebuliser Handset |
| EU/1/14/973/002  | Quinsair          | 240 mg     | Nebuliser solution    | Inhalation use            | Ampoule (LDPE)        | 2.4 mL (100 mg/mL)        | 8 Ampoules + 1 Nebuliser Handset  |